Balneotherapy as a promising method for the correction of dermatologic adverse events of cancer therapy
- Authors: Polonskaia A.S.1, Shatokhina E.A.1,2, Kruglova L.S.1
-
Affiliations:
- Central State Medical Academy of the Office of the President of the Russian Federation
- Medical Research and Education Center of Lomonosov Moscow State University
- Issue: Vol 20, No 6 (2021)
- Pages: 551-558
- Section: Guidelines for practitioners
- URL: https://journals.rcsi.science/1681-3456/article/view/108026
- DOI: https://doi.org/10.17816/rjpbr108026
- ID: 108026
Cite item
Abstract
Cancer treatment with chemotherapy, targeted and immunotherapy is associated with a wide spectrum of dermatologic adverse events. Xerosis (dryness) of the skin is the most prevalent skin side effect in oncologic patients, which occurs both during treatment with "classic" chemotherapy drugs and modern cancer drugs, such as targeted therapy and immunotherapy.
Despite the high prevalence of this side effect, current approaches to the correction of skin xerosis in cancer patients are very limited. At the same time, in the absence of adequate supportive treatment of xerosis, the formation of persistent fissures, eczematization and secondary infection is observed, which may lead to antitumor therapy regimen modification. Thus, optimization of prophylactic and treatment strategies for xerosis in patients treated with anticancer drugs remain an important interdisciplinary problem. Balneotherapy is a promising method for the correction of skin xerosis due to a complex positive effect on the level of skin hydration, a decrease in the intensity of inflammatory processes, a beneficial effect on the state of the skin barrier function, as well as an increase in antimicrobial protection. Available data on the use of balneotherapy in the supportive treatment of skin xerosis as a dermatological adverse event of anticancer therapy confirms the high efficacy and safety, as well as good tolerability of this method in cancer patients.
Full Text
##article.viewOnOriginalSite##About the authors
Aleksandra S. Polonskaia
Central State Medical Academy of the Office of the President of the Russian Federation
Author for correspondence.
Email: dr.polonskaia@gmail.com
ORCID iD: 0000-0001-6888-4760
SPIN-code: 8039-4105
MD, Postgraduate Student
Russian Federation, MoscowEvgeniya A. Shatokhina
Central State Medical Academy of the Office of the President of the Russian Federation; Medical Research and Education Center of Lomonosov Moscow State University
Email: dr.polonskaia@gmail.com
ORCID iD: 0000-0002-0238-6563
SPIN-code: 3827-0100
MD, Dr. Sci. (Med.), Professor
Russian Federation, Moscow; MoscowLarisa S. Kruglova
Central State Medical Academy of the Office of the President of the Russian Federation
Email: kruglovals@mail.ru
ORCID iD: 0000-0002-5044-5265
SPIN-code: 1107-4372
MD, Dr. Sci. (Med.), Professor
Russian Federation, MoscowReferences
- Lacouture ME, Sibaud V, Gerber PA, et al. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines. Ann Oncol. 2021;32(2):157–170. doi: 10.1016/j.annonc.2020.11.005
- Koroleva IA, Bolotina LV, Gladkov OA, et al. Practical recommendations on the management of dermatologic adverse events in patients, treated with targeted anticancer drugs. Malignant Tumors: Practical Recommendations RUSSCO. 2020;10(3s2):88–101. (In Russ). doi: 10.18027 / 2224-5057-2020-10-3s2-42
- Segaert S, Van Cutsem E. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol. 2005;16(9):1425–1433. doi: 10.1093/annonc/mdi279
- Osio A, Mateus C, Soria JC, et al. Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors. Br J Dermatol. 2009;161(3):515–521. doi: 10.1111/j.1365-2133.2009.09214.x
- Galimont-Collen AF, Vos LE, Lavrijsen AP, et al. Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors. Eur J Cancer. 2007;43(5):845–851. doi: 10.1016/j.ejca.2006.11.016
- Common terminology criteria for adverse events (CTCAE) version 4.0. Published: May 28, 2009 (v.4.03: June 14, 2010) [Internet]. US Department of Health and Human Services; National Institute of Health; National Cancer Institute [cited 2022 Jul 13]. Available from: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf.
- Michenko AV, Kruglova LS, Shatokhina EA, et al. Dermatological toxicity of EGFR inhibitors: pathogenetic rationale and an algorithm for acne-like rash correction. Oncohematology. 2021;16(4):50–58. (In Russ). doi: 10.17650/1818-8346-2021-16-4-50-58
- Roé E, García Muret MP, Marcuello E, et al. Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients. J Am Acad Dermatol. 2006;55(3):429–437. doi: 10.1016/j.jaad.2006.04.062
- Ponomarenko GN. General physiotherapy. 5th ed. Moscow: GEOTAR-Media; 2014. 368 p. (In Russ).
- Vorontsova LV. SPA. Guidelines for cosmetologists. Мoscow; 2008. 252 p. (In Russ).
- Matsumoto S. Evaluation of the Role of Balneotherapy in Rehabilitation Medicine. J Nippon Med Sch. 2018;85(4):196–203. doi: 10.1272/jnms.JNMS.2018_85-30
- Merial-Kieny C, Castex-Rizzi N, Selas B, et al. Avène Thermal Spring Water: an active component with specific properties. J Eur Acad Dermatol Venereol. 2011;25(Suppl. 1):2–5. doi: 10.1111/j.1468-3083.2010.03892.x
- Chebassier N, El Houssein O, Viegas I, Dréno B. Stimulatory effect of boron and manganese salts on keratinocyte migration. Acta Derm Venereol. 2004;84(3):191–194. doi: 10.1080/00015550410025273
- Chebassier N, El Houssein O, Viegas I, Dréno B. In vitro induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in keratinocytes by boron and manganese. Exp Dermatol. 2004;13(8):484–490. doi: 10.1111/j.0906-6705.2004.00197.x
- Faga A, Nicoletti G, Gregotti C, et al. Effects of thermal water on skin regeneration. Int J Mol Med. 2012;29(5):732–740. doi: 10.3892/ijmm.2012.917
- Zöller N, Valesky E, Hofmann M, et al. Impact of Different Spa Waters on Inflammation Parameters in Human Keratinocyte HaCaT Cells. Ann Dermatol. 2015;27(6):709–714. doi: 10.5021/ad.2015.27.6.709
- Dechelette C, Belaubre F, Julie S, Charveron M. Avène thermal spring water enhances normal human keratinocyte differentiation. In: World Congress of Dermatology; Buenos Aires; 2007.
- Lehen’kyi V, Vandenberghe M, Belaubre F, et al. Acceleration of keratinocyte differentiation by transient receptor potential vanilloid (TRPV6) channel activation. J Eur Acad Dermatol Venereol. 2011;25(Suppl. 1):12–18.
- Galliano MF, Bäsler K, Caruana A, et al. Protective effect of Aquaphilusdolomiae extract-G1, ADE-G1, on tight junction barrier function in a Staphylococcus aureus-infected atopic dermatitis model. J Eur Acad Dermatol Venereol. 2020;34(Suppl. 5):30–36. doi: 10.1111/jdv.16516
- Eliasse Y, Redoules D, Espinosa E. Impact of Avène Thermal Spring Water on immune cells. J Eur Acad Dermatol Venereol. 2020;34(Suppl. 5):21–26. doi: 10.1111/jdv.16335
- Mahé YF, Martin R, Aubert L, et al. Induction of the skin endogenous protective mitochondrial MnSOD by Vitreoscilla filiformis extract. Int J Cosmet Sci. 2006;28(4):277–287. doi: 10.1111/j.14672494.2006.00333.x
- Mahe YF, Perez MJ, Tacheau C, et al. A new Vitreoscilla filiformis extract grown on spa water enriched medium activates endogenous cutaneous antioxidant and antimicrobial defenses through a potential Toll-like receptor 2/protein kinase C, zeta transduction pathway. Clin Cosmet Investig Dermatol. 2013;6:191–196. doi: 10.2147/CCID.S47324
- Kruglova LS, Shatokhina EA, Kotenko KV, Korchazhkina NB. The use of the physical therapy methods for the rehabilitation of the patients presenting with cancer pathology. Russian Journal of Physiotherapy, Balneology and Rehabilitation. 2016;15(2):97–101. (In Russ). doi: 10.18821/1681-3456-2016-15-2-97-101
- Persiyanova-Dubrova AL, Badalov NG, Kavunenko DV. The specific methodological features of scientific research in the field of balneotherapy. Problems of Balneology, Physiotherapy, and Exercise Therapy. 2019;96(1):63–68. (In Russ). doi: 10.17116/kurort20199601163
- Dalenc F, Ribet V, Rossi AB, et al. Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study. Eur J Cancer Care (Engl). 2018;27(1). doi: 10.1111/ecc.12735